Corteva (NYSE:CTVA) Price Target Raised to $91.00 at Argus

Corteva (NYSE:CTVA) had its price objective boosted by Argus from $80.00 to $91.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Argus currently has a buy rating on the stock.

Several other equities analysts also recently weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $88.00 price objective on shares of Corteva in a report on Thursday, February 5th. BNP Paribas Exane lifted their price objective on shares of Corteva from $72.00 to $74.00 in a research note on Monday, March 9th. Wells Fargo & Company boosted their target price on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Corteva in a research report on Monday, December 29th. Fourteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and an average target price of $83.45.

Corteva Stock Up 0.9%

Shares of NYSE CTVA opened at $83.70 on Tuesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The stock has a market capitalization of $56.19 billion, a PE ratio of 52.97, a P/E/G ratio of 2.83 and a beta of 0.72. Corteva has a one year low of $53.40 and a one year high of $84.00. The business’s fifty day moving average price is $76.82 and its 200-day moving average price is $69.78.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting the consensus estimate of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts anticipate that Corteva will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, March 2nd. Corteva’s dividend payout ratio is presently 45.57%.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.15% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Activest Wealth Management raised its position in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares in the last quarter. JPL Wealth Management LLC purchased a new position in Corteva during the third quarter worth about $25,000. True Wealth Design LLC grew its position in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares in the last quarter. Total Investment Management Inc. bought a new position in Corteva in the 2nd quarter worth about $27,000. Finally, Garton & Associates Financial Advisors LLC bought a new position in Corteva in the 4th quarter worth about $27,000. 81.54% of the stock is owned by institutional investors.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.